Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
Clinical trial NCT07073638 · RECRUITING
Trial details
- NCT number
- NCT07073638
- Sponsor
- Thirty Respiratory Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-13
- Primary completion
- 2026-09-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.